Clinical Trial Update: Sunitinib in Treating Patients With Locally Advanced Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sunitinib in patients with locally advanced bladder cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Sunitinib (sunitinib)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-04-16